The human CDH1α, human CDH1β and mouse CDH1 nucleotide sequences reported in this paper have been deposited in the GenBank database under accession numbers AF083810, AF083809 and AF433157.
Synopsis
The timely destruction of key regulators through ubiquitin-mediated proteolysis ensures the orderly progression of cell cycle. The anaphase-promoting complex (APC) is a major component of this degradation machinery and its activation is required for the execution of critical events. Recent studies have just begun to reveal the complex control of APC through a regulatory network involving WD40 repeat proteins CDC20 and CDH1. Here we report on the identification and characterization of human CDH1β, a novel alternatively spliced isoform of CDH1. Both CDH1α and CDH1β can bind to APC and stimulate the degradation of cyclin B1, but they are differentially expressed in human tissues and cells. CDH1α contains a nuclear localization signal which is absent in 
RESULTS

CDC20 and CDH1 represent two multigene families
The identification of Drosophila and Xenopus CDH1 [8, 10] facilitates the cloning of human and mouse orthologs. The isolation and characterization of human CDH1 has been reported previously [14, 19, 39] . In an early and independent attempt to assemble full-length CDH1 cDNAs, we also obtained several human and mouse EST clones sharing striking sequence homologies with frog CDH1. The human and mouse CDH1 sequences with a complete coding region were determined and deposited in GenBank under accession numbers AF083810 and AF083809 (submitted on August 12, 1998).
Human and mouse CDH1 proteins ( Figure 1A ) share 98.4% identity in an overlap of 493 amino acid residues. The seven WD40 repeats are identical in the two proteins except for one E-to-D substitution at the 193rd residue. The nine putative CDK phosphorylation sites (shaded in Figure 1A ) are also conserved. Since a similarity search generated more CDC20-/CDH1-related sequences than expected, we constructed a phylogenetic tree of all CDC20/CDH1 homologs from various species ( Figure 1B ) in order to better understand the genetic relationship.
Notably, there is one additional CDC20 paralog in budding yeast. This protein named AMA1/CDC20B ( Figure 1B ) is required for sporulation and has been implicated as a meiosis-specific activator of APC [40] . In fission yeast, five CDC20/CDH1 homologs can be identified. In addition to the documented CDC20A (SLP1) and CDH1A (SRW1/STE9), two CDC20 paralogs (CDC20B and CDC20C) and another CDH1 paralog (CDH1B or MFR1 or FZR1) were found. In the phylogenetic tree, the fission yeast CDC20B and CDC20C cluster with budding yeast AMA1/CDC20B, while the fission yeast CDH1A and CDH1B group with budding yeast CDH1. Interestingly, CDH1B/MFR1/FZR1 has been shown to be another meiosis-specific activator of APC required for sporulation [41, 42] . The bootstrap supports for these clusters are statistically very significant (100% or 95%). We postulate that different CDC20/CDH1 homologs in fission yeast might serve redundant and non-redundant functions. It would be of interest to see how they cooperate to ensure the precise spatiotemporal order of APC activation.
Multiple CDC20 and CDH1 homologs were also noted in higher eukaryotes ( Figure   1B ). Thus Arabidopsis thaliana (thale cress) has at least one CDH1 and three closely related CDC20 homologs (CDC20A, CDC20B, and CDC20C). Likewise, Drosophila (fruit fly) possesses CDC20, CDH1/FZR and CDH2/FZR2 [9] . We predict that more vertebrate CDC20/CDH1 homologs will be identified as the genome projects progress. CDC20 and CDH1 represent two multigene families of WD40 repeat proteins critically involved in the regulation of APC. It is important to compare and contrast the functions of different CDC20/CDH1-like proteins in one species.
Chromosomal mapping and genomic organization of human CDH1 locus
We determined the chromosomal map location of human CDH1 gene by sequence alignment. Using cDNA information we identified two genomic clones that contain the coding and non-coding regions of human CDH1. These were cosmids R33374 and R31109 from a genomic library constructed at the Lawrence Livermore National Laboratory (GenBank AC005787 and AC005786). Both clones map to chromosome 19p13.3. The human CDH1 locus (FZR1/ HCDH1) was noted to be closely linked to nuclear factor I/C (NFIC) and Sox-like transcription factor (HMG20B or SOXL). This map location of CDH1 was confirmed by PCR analysis and by restriction mapping. We verified that the distance between NFIC and FZR1 is within 30kb, while the FZR1 and HMG20B genes are separated by no more than 37kb (Figure 2A ).
Approximately 43kb of assembled sequence from cosmid R33374 was obtained.
Human CDH1 locus spans 29.8kb. The sizes of all exons and introns were verified by PCR analysis. The gene contains at least 14 exons varying in size from 63bp to 1.4kb ( Figure 2B ). The sequences of all splice junctions and of the 5' upstream region were confirmed by direct sequencing of PCR products amplified from human genomic DNA.
Identification of an alternatively spliced isoform of human CDH1
We isolated an alternative form of CDH1 from a human heart cDNA library (GenBank AF433157). We noted that this cDNA represents an alternatively spliced isoform. This novel isoform designated CDH1β can be produced by splicing exon 8 to exon 5, skipping exons 6 and 7 (267 nucleotides; Figure 2B ). The CDH1β protein lost 89 residues containing one WD40 repeat, four CDK phosphorylation sites and a cluster of positively charged residues ( Figure 1A ). This raises the possibility that CDH1β might function or be regulated in a manner different from the original isoform of human CDH1 renamed as CDH1α. Noteworthily, CDH1β has been independently isolated by another group (GenBank AB013463) and by the Mammalian Gene Collection at the National Institutes of Health (http://mgc.nci.nih.gov), suggesting that it is unlikely a cloning artifact or an erroneously spliced RNA. To this end, we tested several sets of primers for amplification of human CDH1α and CDH1β in model experiments using CDH1α and CDH1β plasmids as template. In our experiments primer sets A and B were able to differentially amplify CDH1α and CDH1β. Figure 3B shows that primer set A can specifically amplify CDH1α from templates containing either CDH1α alone (lane 1) or CDH1α plus CDH1β (lane 4). Likewise, primer set B is specific for CDH1β from templates containing CDH1β alone (lane 2) or CDH1α plus CDH1β (lane 3). Next, we tested RNAs from various human tissues and cells using primer sets A ( Figure 3C ) and B ( Figure 3D ). We noted that both CDH1α and CDH1β were detected in multiple sources.
Differential expression of
The CDH1α transcript is relatively more abundant in heart, liver, spleen, HeLa cells, HepG2 cells and H1299 cells ( Figure 3C ). In contrast, the CDH1β mRNA is expressed in heart, spleen, and H1299 lung cancer cells ( Figure 3D ). The identity of the CDH1α and CDH1β amplification products was verified by DNA sequencing. Thus, CDH1β can be found in some tissues and cells albeit in low abundance. The distinct expression patterns of CDH1α and CDH1β suggest that they might serve different and complementary functions.
APC-binding and APC-activating activity of CDH1β in HeLa cells
While our study is in progress, four CDH1 homologs have been identified in chick [43] .
All of them bind and activate APC in vitro and in cultured cells. To our surprise, all four chicken CDH1 homologs contain sequences corresponding to exons 6 and 7 of human CDH1 gene. They represent four different gene loci and were not produced by alternative splicing. Thus, none of them are structurally equivalent to human CDH1β. However, vertebrate CDH1 variants generated through distinct mechanisms could still be functionally related. Based on this reasoning, human CDH1β isoform and chicken CDH1 homologs could serve similar or related functions intracellularly. To test this hypothesis, we asked whether human CDH1β binds to and activates APC in HeLa cells. To determine whether association of CDH1β with APC leads to activation of proteolysis, we constructed a reporter plasmid expressing the firefly luciferase fused to the D box of cyclin B1. This plasmid (pCYCB1-Luc), when transfected into cells, can reflect the in vivo activity of the APC-dependent ubiquitination and degradation system in real time [24, 44] . We observed that the overexpression of either CDH1α or CDH1β protein significantly increased the degradation of the cyclin B1-luciferase fusion protein ( Figure 4D ). APC-dependent proteolysis is through proteasome. If CDH1α and CDH1β specifically target APC, their stimulatory effect on cyclin B1 degradation should be responsive to proteasome inhibitors. Indeed, when we incubated the CDH1α-and CDH1β-expressing cells with proteasome inhibitor MG-132, the CDH1α-/CDH1β-induced degradation of cyclin B1-luciferase was prevented ( Figure 4D , compare filled with unfilled columns). Thus, both CDH1α and CDH1β are specific activators of APCdependent and proteasome-mediated destruction of cyclin B1 in HeLa cells.
Differential localization of CDH1α and CDH1β
Next we queried for the subcellular localization of CDH1α and CDH1β. We generated two specific antisera against CDH1 (α-CDH1N and α-CDH1C, Figure 1A ) and stained cultured cells using the purified antibodies. As a first step, the specificity of the anti- We were concerned that CDH1β was not detected in Western blotting and immunostaining due to the low abundance ( Figure 5A ). To remedy this and to distinguish the CDH1β staining from that of CDH1α, we stained for epitope-tagged CDH1α and Both CDH1α and CDH1β bind to and activate APC (Figure 4 ), but they localize to different subcellular compartments ( Figure 5B ). In this setting, CDH1α and CDH1β could encounter distinct sets of APC substrates at different locales. For example, they are able to activate cyclin B1 destruction ( Figure 4B ) and might cooperate with each other to mediate the timely and orderly degradation of nuclear and cytoplasmic cyclin B1. In another case, they might act differentially on the nuclear cyclins such as cyclin A and cyclin E. To explore how expression of CDH1α and CDH1β might influence the proteolysis of cyclin A, we overexpressed HA-CDH1α and HA-CDH1β in HeLa cells and co-stained for CDH1 and cyclins ( Figure 5C ). In agreement with previous studies [47] , ambient cyclin A is predominantly nuclear ( Figure 5C , panels 2 and 5). We observed that CDH1α co-localized with cyclin A to the nucleus ( Figure 5C 
CDH1α contains a nuclear localization signal which is absent in CDH1β
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The differential localization of CDH1α and CDH1β ( Figure 5 ) suggests that the peptide fragment present in CDH1α but absent in CDH1β might dictate nuclear import. Indeed, a cluster of nine positively charged residues can be found in that fragment (Figure 1 , residues highlighted by "#"). This cluster might act as a nuclear localization signal in CDH1α. To test this hypothesis, we fused the peptide sequence encoded by exons 6 and 7 of CDH1α to green fluorescent protein (GFP). When overexpressed in HeLa cells, GFP alone was diffusely found in both the cytoplasm and the nucleus ( Figure 6, panel 1) . In contrast, when we overexpressed the chimeric protein GFPE67 in cells, the heterologous GFP protein was targeted into the nucleus by the nuclear localization signal resided apparently in the sequences encoded by exons 6 and 7 of CDH1α ( Figure 6 , panel 2).
Thus, CDH1α harbors a nuclear localization signal which is absent in CDH1β.
Identification and further characterization of this nuclear localization signal are reported elsewhere [46] .
Differential activity of human CDH1α and CDH1β in Xenopus embryos
The co-localization studies shown above suggest that human CDH1β might be a poor activator of the APC-mediated degradation of nuclear cyclin A ( Figure 5C ). To compare the global influence of human CDH1α and CDH1β on cell cycle progression, we used the Xenopus embryo microinjection system. We and others have shown that the injection of Xenopus CDH1 RNA into one blastomere of two-cell stage Xenopus embryos sufficiently induced a cell cycle arrest at the midblastula transition (MBT) due to continued activation of APC [30, 48] . As such, the overexpression of CDH1 was phenotypically silent before the MBT (stage 8.5) and the cell division cycles seemed normal. However, immediately after the MBT the cells on the CDH1-injected side were significantly larger than those on the uninjected side. Indeed, when we overexpressed human CDH1α in early Xenopus embryos by microinjecting CDH1α RNA into one of the two blastomeres in stage 2, we observed a post-MBT arrest ( Figure 7A, panel 3) exactly as described for Xenopus CDH1 ( Figure 7B ). As shown in a CDH1α-injected embryo at late stage 9 ( Figure 7A, panel 3) , the cells overexpressing CDH1α were more than five times bigger, implicating that the inhibition lasted for at least several cycles of 14 cell division. In control groups, the uninjected, mock-injected, and antisense CDH1α-/CDH1β-injected embryos did not arrest cell division during the MBT ( Figure 7A , panels 1 and 2; Figure 7B ). Interestingly, the injection of human CDH1β RNA is phenotypically silent ( Figure 7A, panel 4 and Figure 7B ) and the injected embryos were indistinguishable from the controls ( Figure 7A , compare panel 4 with panels 1 and 2).
Thus, human CDH1α and CDH1β have differential APC-activating activity in Xenopus embryos. CDH1β is incapable of inducing the post-MBT cell cycle arrest.
DISCUSSION
Here we documented the differential expression, subcellular localization and activity of CDH1α and CDH1β, two functional isoforms of human CDH1. CDC20 and CDH1 represent two multigene families of WD40 repeat proteins that are key regulators of APC (Figure 1) . A novel alternatively spliced isoform of human CDH1, named CDH1β, was identified from a heart cDNA library ( Figure 1 and Figure 2 ). The two CDH1 isoforms were expressed to different levels in various human tissues and cells (Figure 3 ). Both isoforms associate with APC subunit CDC27 and stimulate the APC-dependent proteolysis of cyclin B1 in cultured cells (Figure 4) . CDH1α, which harbors a nuclear localization signal absent in CDH1β (Figure 6 ), localizes to the nucleus ( Figure 5 ). In contrast, CDH1β is cytosolic ( Figure 5 ). Finally, CDH1α, but not CDH1β, co-localizes with nuclear cyclin A, activates cyclin A degradation, and induces a post-MBT arrest in cell cycle progression in Xenopus embryos ( Figure 5 and Figure 7) . Our work suggests a complex spatial and temporal control of APC activation during the cell cycle.
One salient finding in our study is the differential expression, localization and activity of human CDH1α and CDH1β generated through alternative splicing. Alternative splicing is very common in human cells and approximately 60% of human genes are estimated to have two or more transcripts [49] . Among the various types of alternative splicing that give rise to multiple isoforms of a gene, exon skipping can be caused by exonic and intronic mutations [50] . In this context, it would be of interest to identify and characterize the signals and mechanisms through which the production of CDH1β is induced.
Both CDH1α and CDH1β can bind to the APC complex and activates the APCdependent degradation of cyclin B1 in cultured cells (Figure 4) . However, the presence of CDH1α and CDH1β in different abundance ( Figure 3 ) and at different locales ( Figure 5) suggests that they might play different roles in cell cycle regulation. In line with this, we observed that they showed differential activity in the activation of APC both in cultured human cells ( Figure 5C ) and in Xenopus embryos ( Figure 7) . As yet the mechanism of the differential APC-activating activity of the two isoforms is not fully understood. One possibility is that CDH1α and CDH1β may be active on different sets of substrates. We note that some of our data are in support of this model. Thus, both CDH1α and CDH1β bind to APC and stimulate the degradation of cyclin B1 (Figure 4 ). Cyclin B1 shuttles between the nucleus and the cytoplasm [47] while the cyclin B1-luciferase fusion protein used in this study is both cytoplasmic and nuclear (data not shown). This localization pattern is compatible with the observed degradation of cyclin B1 by both CDH1α and CDH1β. It is also noteworthy that cyclin B1 destruction also takes place at metaphase when the nuclear envelope has been broken down [51] . In this scenario, cyclin B1 and These CDH1 homologs are plausibly derived from gene duplications. None of the four chicken CDH1 homologs were generated through alternative splicing. Neither were they structurally equivalent to human CDH1β identified in this work. Up to date human orthologs of the four chicken CDH1 proteins have not been described except for the original human CDH1α isoform and another EST clone possibly orthologous to the most divergent ChkCDH1-D. With the working draft of human genome sequence available, we are still uncertain whether there are four human CDH1 loci corresponding to those in chick. It is not impossible that at least some of the gene duplication events leading to the production of four CDH1 homologs in chick might have taken place after the separation of birds from other vertebrates. On the other hand, it remains to be seen whether CDH1 isoforms orthologous to human CDH1β exist in other species including chick.
Nevertheless, our working model is that the various CDH1 isoforms in vertebrates have differential activity on different sets of targets. In this regard, gene duplication, which produced four CDH1 homologs in chick, and alternative splicing, which led to the formation of human CDH1β, likely represent two major mechanisms by which CDH1 isoforms could be generated. According to our model, the differential activity of CDH1α and CDH1β in Xenopus embryos is attributed to their differential ability to activate the degradation of different targets such as cyclin A. 
